IDXX IDEXX Laboratories, Inc.

IDXX IDEXX Laboratories, Inc.

Healthcare · Diagnostics & Research

Market read

Scan convergence 1 scan as of 2026-10-16 1 neutral converging

POC $562.34 · VWAP $601.96 · -6.9% vs 12m avg buyer

collapse vol: compressedchurn: quiet as of

Insiders quiet 0 buy / 0 sell · Form 4, 90d

Coverage

1 watchlist

Watchlists @livestock-disease

IDXX Price Structure

Loading chart…

Loading timeframes…

Peers

Every watchlist IDXX belongs to, members best 30-day change first — IDXX highlighted in place. Each pill: 30d change, 1d/7d, and a close spark over the last 30 calendar days (~21 sessions); hover for price, RSI, and the full chart.

Next earnings IDXX reports in 16 days Nov 2

Last report Aug 4

Reported the quarter ending 2026-06-30: revenue $1.22B, diluted EPS $4.27, net income $338M (SEC filing). Across the print the stock moved +3.0% (close before → first close after).

full note →

Against street estimates

How IDXX's reported EPS compared with analyst consensus. Street estimates are single-source vendor consensus (yfinance). Actuals are vendor consensus-basis EPS (often non-GAAP); edgarEps is GAAP diluted from filings — disputed flags large disagreement only. EPS only.

8 most recent of 11 quarters · newest report Aug 4 · projection Oct 16

Result
Aug 4 3.934.27+8.5%Beat
May 5 3.413.47+1.7%In line
Feb 2 2.943.08+4.8%Beat
Nov 3 '25 3.153.40+8.1%Beat
Aug 4 '25 3.303.63+10.0%Beat
May 1 '25 2.842.96+4.1%Beat
Feb 3 '25 2.402.62+9.2%Beat
Oct 31 '24 2.692.80+4.3%Beat